HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jian Li Selected Research

Immunotherapy

3/2024Drug Repurposing of ACT001 to Discover Novel Promising Sulfide Prodrugs with Improved Safety and Potent Activity for Neutrophil-Mediated Antifungal Immunotherapy.
3/2024Helicobacter pylori and immunotherapy for gastrointestinal cancer.
2/2024Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancer.
2/2024Disitamab vedotin (RC48) plus toripalimab for HER2-expressing advanced gastric or gastroesophageal junction and other solid tumours: a multicentre, open label, dose escalation and expansion phase 1 trial.
1/2024Efficacy and Safety of the MDM2-p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series.
1/2024ADGRE5-centered Tsurv model in T cells recognizes responders to neoadjuvant cancer immunotherapy.
1/2024Multi-omics of the gut microbial ecosystem in patients with microsatellite-instability-high gastrointestinal cancer resistant to immunotherapy.
12/2023The tumor immune microenvironment remodeling and response to HER2-targeted therapy in HER2-positive advanced gastric cancer.
11/2023Copper-Bacteriochlorin Nanosheet as a Specific Pyroptosis Inducer for Robust Tumor Immunotherapy.
11/2023A pilot study of cord blood-derived natural killer cells as maintenance therapy after autologous hematopoietic stem cell transplantation.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jian Li Research Topics

Disease

660Neoplasms (Cancer)
12/2024 - 04/2002
260Infections
05/2024 - 10/2002
156Inflammation (Inflammations)
06/2024 - 12/2004
94Neoplasm Metastasis (Metastasis)
03/2024 - 01/2007
77Body Weight (Weight, Body)
02/2024 - 05/2003
74Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 04/2002
67Breast Neoplasms (Breast Cancer)
12/2024 - 01/2007
64Hepatocellular Carcinoma (Hepatoma)
04/2024 - 11/2006
59Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2023 - 01/2009
52Hypoxia (Hypoxemia)
01/2024 - 01/2002
51Pain (Aches)
02/2024 - 05/2005
50Fibrosis (Cirrhosis)
05/2024 - 09/2002
47Carcinogenesis
12/2024 - 03/2011
44Stomach Neoplasms (Stomach Cancer)
05/2024 - 09/2007
43Lung Neoplasms (Lung Cancer)
02/2024 - 01/2008
42Malaria
03/2024 - 01/2009
40Insulin Resistance
03/2024 - 12/2007
37Hemorrhage
04/2024 - 12/2004
37POEMS Syndrome (Syndrome, POEMS)
11/2023 - 11/2010
36Type 2 Diabetes Mellitus (MODY)
04/2024 - 08/2008
36Alzheimer Disease (Alzheimer's Disease)
04/2024 - 05/2007
36Carcinoma (Carcinomatosis)
08/2022 - 05/2006
35Wounds and Injuries (Trauma)
04/2024 - 06/2006
32COVID-19
04/2024 - 01/2020
32Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
11/2023 - 07/2010
29Obesity
02/2024 - 09/2010
28Thrombosis (Thrombus)
11/2023 - 02/2006
27Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2024 - 03/2005
27Hypertension (High Blood Pressure)
12/2023 - 04/2011
26Sepsis (Septicemia)
01/2024 - 03/2012
26Myocardial Infarction
01/2024 - 08/2003
25Amyloidosis
05/2024 - 06/2011
25Thalassemia
11/2023 - 10/2003
24Disease Progression
03/2024 - 01/2010
24Multiple Myeloma
01/2024 - 10/2009
23Non-alcoholic Fatty Liver Disease
05/2024 - 03/2014
23Lymphoma (Lymphomas)
11/2023 - 01/2015
23Esophageal Squamous Cell Carcinoma
11/2022 - 06/2007
22Virus Diseases (Viral Diseases)
04/2024 - 11/2009
22Necrosis
01/2024 - 09/2007
22Atherosclerosis
11/2023 - 09/2010
22Atrial Fibrillation
08/2022 - 08/2008
22Respiratory Tract Infections (Respiratory Tract Infection)
07/2022 - 10/2013
21Pneumonia (Pneumonitis)
05/2024 - 10/2007
21Critical Illness (Critically Ill)
01/2023 - 12/2007
20Cardiovascular Diseases (Cardiovascular Disease)
07/2024 - 11/2010
20Esophageal Neoplasms (Esophageal Cancer)
04/2024 - 04/2000
20Stroke (Strokes)
03/2024 - 04/2012
20Pancreatic Neoplasms (Pancreatic Cancer)
04/2023 - 01/2013
19Gastrointestinal Neoplasms (Gastrointestinal Cancer)
03/2024 - 05/2018

Drug/Important Bio-Agent (IBA)

224Proteins (Proteins, Gene)FDA Link
06/2024 - 07/2002
145Biomarkers (Surrogate Marker)IBA
04/2024 - 10/2005
89Colistin (Coly-Mycin)FDA Link
11/2023 - 05/2003
88MicroRNAs (MicroRNA)IBA
12/2023 - 11/2009
85Anti-Bacterial Agents (Antibiotics)IBA
04/2024 - 09/2006
78Messenger RNA (mRNA)IBA
04/2024 - 07/2005
68CytokinesIBA
05/2024 - 12/2004
56Glucose (Dextrose)FDA LinkGeneric
02/2024 - 09/2006
52Polymyxins (Polymyxin)IBA
12/2023 - 09/2006
51Therapeutic UsesIBA
07/2024 - 08/2005
50DNA (Deoxyribonucleic Acid)IBA
12/2023 - 03/2003
48Polymyxin B (Aerosporin)FDA LinkGeneric
01/2024 - 12/2007
47Long Noncoding RNAIBA
03/2024 - 01/2015
46Immune Checkpoint InhibitorsIBA
05/2024 - 01/2019
39RNA (Ribonucleic Acid)IBA
03/2024 - 03/2003
37LipidsIBA
05/2024 - 05/2009
37AntioxidantsIBA
02/2024 - 12/2007
37Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2023 - 12/2003
35Cisplatin (Platino)FDA LinkGeneric
05/2024 - 03/2007
34EnzymesIBA
01/2024 - 07/2005
33AntigensIBA
03/2024 - 04/2002
33VaccinesIBA
01/2023 - 04/2002
32Dexamethasone (Maxidex)FDA LinkGeneric
03/2024 - 10/2009
28Tyrosine Kinase InhibitorsIBA
11/2023 - 10/2005
27Doxorubicin (Adriamycin)FDA LinkGeneric
05/2024 - 01/2014
26Polysaccharides (Glycans)IBA
04/2024 - 09/2007
25Interleukin-6 (Interleukin 6)IBA
04/2024 - 10/2012
24LigandsIBA
05/2024 - 01/2014
24Transcription Factors (Transcription Factor)IBA
01/2024 - 01/2011
24Phosphotransferases (Kinase)IBA
06/2023 - 10/2005
23Indicators and Reagents (Reagents)IBA
05/2024 - 12/2008
23Peptides (Polypeptides)IBA
04/2024 - 04/2004
23LipopolysaccharidesIBA
01/2024 - 02/2011
23Small Interfering RNA (siRNA)IBA
01/2024 - 09/2010
23Insulin (Novolin)FDA Link
09/2023 - 12/2007
22Reactive Oxygen Species (Oxygen Radicals)IBA
07/2024 - 02/2006
22Imatinib Mesylate (Gleevec)FDA Link
04/2024 - 03/2011
22Antiviral Agents (Antivirals)IBA
04/2024 - 05/2007
22Bortezomib (Velcade)FDA Link
03/2024 - 10/2009
21CollagenIBA
04/2024 - 09/2002
21Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2022 - 09/2007
20ErbB Receptors (EGF Receptor)IBA
02/2022 - 01/2008
19CateninsIBA
05/2024 - 12/2011
19Oxygen (Dioxygen)IBA
05/2024 - 01/2012

Therapy/Procedure

394Therapeutics
07/2024 - 07/2004
140Drug Therapy (Chemotherapy)
05/2024 - 09/2003
57Immunotherapy
03/2024 - 04/2010
40Radiotherapy
02/2024 - 09/2003
21Aftercare (After-Treatment)
09/2023 - 05/2005
20Length of Stay
11/2023 - 11/2009